Notification of Interest

RNS Number : 4911O
Futura Medical PLC
06 March 2009
 




For immediate release 

6 March 2009





Futura Medical plc

('Futura' or 'the Company')


Notification of Interest


Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, was notified on 6 March 2009 thatfollowing the purchase of shares in the Company on the same day P Mahon holds 2,083,302 ordinary shares in Futura, representing 3.3% of the issued share capital of the Company. 




For any further information please contact:



Futura Medical plc


James Barder, Chief Executive

Tel: +44 (0) 1483 685 670



mail to: james.barder@futuramedical.co.uk

www.futuramedical.co.uk 



Canaccord Adams


Ryan Gaffney / Adria Da Breo Richards

Tel: +44 (0) 20 7050 6500 



For media enquiries please contact: 




Buchanan Communications


Mark Court / Rebecca Skye Dietrich / Stasa Filiplic

Tel: +44 (0) 20 7466 5000

 


Notes to Editors


Futura Medical plc


Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.


Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.


www.futuramedical.co.uk




This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLCKAKPABKDPNK
UK 100

Latest directors dealings